Home  About us  Contact
 

Topical Imiquimod 5% Cream (topical + imiquimod_5%_cream)

Distribution by Scientific Domains
Medical Sciences100%

Selected Abstracts

Extramammary Paget's disease treated with topical imiquimod 5% cream

DERMATOLOGIC THERAPY, Issue 4 2010
Sue-Ann J. E. Ho
ABSTRACT Extramammary Paget's disease (EMPD) is a rare cutaneous, intraepithelial adenocarcinoma usually found in the apocrine gland bearing areas. It is traditionally treated with surgery but has a high rate of recurrence. Of late, topical imiquimod 5% cream has come into use as another treatment option. We present two cases of EMPD in Asian skin treated successfully with topical imiquimod 5% cream. [source]

Successful treatment of Vulvar Bowen's disease with topical imiquimod 5% cream

INTERNATIONAL JOURNAL OF DERMATOLOGY, Issue 2 2006
Yeon Jeong Kim MD
No abstract is available for this article. [source]

Imiquimod in the treatment of eyelid basal cell carcinoma

ACTA OPHTHALMOLOGICA, Issue 5 2007
Jari Leppälä
ABSTRACT. Purpose:, To assess the efficacy and safety of topical imiquimod 5% cream in the treatment of eyelid basal cell carcinoma. Methods:, Four patients with eyelid basal cell carcinoma were treated with imiquimod once daily, 5 days per week, for 6 weeks. Tissue biopsy was taken and clinical examination with slit-lamp microscopy was performed at the beginning of the study and after a follow-up of 12 weeks. Photographic follow-up was performed from the baseline visit to 6, 12 and 26 weeks. Results:, In the 12-week follow-up after imiquimod treatment, histopathological tissue sample analysis showed no signs of basal cell carcinoma in any of the patients. Conclusions:, The results indicate that 5% imiquimod cream with topical administration may represent a new therapy option for eyelid basal cell carcinoma. [source]